Physician profile
John H Acker
NPI 1497756241
$4,340.34
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $137 · 2021: $1,117 · 2022: $1,149 · 2023: $1,126 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,196.56 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $817.76 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $662.24 | 2021-2023 | Xarelto |
| Amgen INC. | $331.88 | 2019-2023 | Repatha |
| Pfizer INC. | $276.76 | 2020-2023 | |
| Boston Scientific Corporation | $261.85 | 2019-2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $152.92 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $107.84 | 2019-2023 | |
| Philips North America LLC | $102.11 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $99.12 | 2019-2022 | |
| Abbott Laboratories | $62.25 | 2021-2022 | |
| Abiomed | $55.91 | 2023 | Impella |
| Atricure, INC. | $47.37 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $43.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.60 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $22.24 | 2019 | |
| Vital Connect, INC | $20.38 | 2024 | Vitalpatch Rtm |
| Novo Nordisk INC | $17.68 | 2022 | |
| Lantheus Medical Imaging, INC. | $17.13 | 2021 | |
| Alnylam Pharmaceuticals INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Acker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.